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A Corrigendum on
Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections 
in the USA: An Economic Modeling Study. 
by Lenoir-Wijnkoop I, Merenstein D, Korchagina D, Broholm C, Sanders ME and Tancredi D (2019) 
Front. Pharmacol. 10:980. doi: 10.3389/fphar.2019.00980
In the original article, there was an error. There is a mistake in the Funding statement. The mention 
that the funder, Chr. Hansen, was not involved in the writing of the manuscript is incorrect. A 
correction has been made to the Funding statement:
“This project was supported by an unrestricted grant from Chr. Hansen. The funder 
was not involved in the study design, collection, analysis, interpretation of data or the 
decision to submit it for publication”
Furthermore, there is a mistake in the Conflict of Interest Statement. The declaration that the 
author DM consulted Bayer and Pharmative was erroneously omitted. A correction has been made 
to the Conflict of Interest Statement:
“Author CB is an employee at Chr. Hansen. Author DK is employed by IQVIA. Author 
MS serves as an executive science officer for the International Scientific Association for 
Probiotics and Prebiotics. She also reports personal fees outside the submitted work from 
the following entities: International Scientific Association for Probiotics and Prebiotics, 
Pharmavite, CD Investments, Dannon, Danone USA, Yakult, California Dairy Research 
Foundation, Winclove BioSciences BV, Nestle, Williams Mullen, New Chapter, Dutch 
Mill, Clorox, Pfizer, Visalia Dairy Company, Procter & Gamble, Kelley Drye & Warren 
LLP, Kellogg, Trouw Nutrition, Kerry, JHeimbach LLC, General Mills, Probi, and 
Medscape. Author DM declares consulting for Bayer and Pharmavite. The remaining 
authors declare that the research was conducted in the absence of any commercial or 
financial relationships that could be construed as a potential conflict of interest.”
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Lastly, there was a mistake in the Methods, section Model 
Inputs and Data Sources, sub-section Probiotic Effect. The RTI 
incidence and antibiotic prescription rate was provided in the 
incorrect unit. A correction has been made to the Methods, section 
Model Inputs and Data Sources, sub-section Probiotic Effect, 
paragraph one:
“The clinical effects of probiotics were obtained from 
the meta-analyses published by the YHEC (King et al., 
2014) and Cochrane (Hao et al., 2015). These were 
used to conduct two independent scenario analyses 
comparing generalized probiotic use versus non-use, 
each based on different assumptions: YHEC showed 
a significantly shorter duration of −0.77 days [−1.50 
to −0.04] on an average duration of 7.4 days per 
episode of RTI, among otherwise healthy children 
and adults taking probiotics compared to those taking 
placebo. The Cochrane study reported that probiotics 
significantly reduced RTI duration by 1.89 days [1.75 
to 2.03] per episode of an average duration of 8.82 days 
and RTI incidence by 30% (RR = 0.70 [0.50 to 0.84]) 
(Table 1). The authors also found a significant reduction 
of the antibiotic prescription rate of 35% (RR = 0.65 
[0.45 to 0.94]), which was applied to both scenarios.” 
Additionally, the YHEC meta-analysis studied the 
impact of probiotics on work absenteeism. The reported 
standardized mean difference (SMD) in the number of 
days absent from work was used to estimate the impact 
of probiotics on productivity loss. The Cochrane meta-
analysis focused on unvaccinated individuals; therefore, 
no impact of probiotics sourced from the Cochrane 
meta-analysis was applied in vaccinated patients.
The authors apologize for these errors and state that they do 
not change the scientific conclusions of the article in any way.
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